Led · Equity · Aug 2024

GoWit builds and operates an omnichannel, AI-driven platform that enables full-funnel retail media activation—covering on-site, off-site, and in-store placements. The system lets retailers quickly launch and scale ad-monetization programs, provides brands with unified reporting and predictive automation, and gives agencies a single interface to run data-rich campaigns with transparent performance metrics. GoWit’s network is already trusted by major retailers and marketplaces such as Carrefour (Turkey), Union Coop (UAE), Raneen (Egypt), Toters Delivery (Lebanon), Mumzworld (UAE), and Heureka Group (Czech Republic). The company also partners with ecosystem players like Goldbach, Spike Media, and Akinon to build a connected retail media infrastructure. Today, GoWit serves more than 7,000 brands in over 20 markets. With fresh capital, it intends to accelerate expansion across EMEA and develop next-generation AI tools to further boost ad performance, data intelligence, and monetization capabilities.

Participated · Series G · Oct 2020

Yuanfudao is a Beijing-based online education platform founded in 2012 that provides a range of digital learning products. Its offerings include a live tutoring platform (Yuanfudao), Zebra AI Class, the online question bank Yuantiku, the question-searching app Xiaoyuan Souti and the arithmetic checking app Xiaoyuan Kousuan. The company has established multiple teaching and research centers and branches across China, including Wuhan, Xi’an, Zhengzhou, Nanjing, Chengdu, Jinan, Changsha, Tianjin, Chongqing, Shenyang, Changchun and Hefei. It employs more than 30,000 people. Following its latest financings the company’s valuation rose to US$15.5 billion. Yuanfudao plans to use the new funding to accelerate new curriculum product development and expand its online education service system. Yuanfudao is a Chinese online education company that provides online homework assistance and structured educational plans for students. Its apps were ranked the top education apps in China for in-app purchases between January and March, according to App Annie. The company reports 400 million users and operates 11 teaching and curriculum development centers across China. Demand for its services has surged as social distancing has forced schools to shift classes online. Yuanfudao recently raised $1 billion in funding, leading to a $7.8 billion valuation—more than double its $3 billion valuation from last year. Investors in the company include Tencent Holdings, Hillhouse Capital Group, Boyu Capital, and IDG Capital. Yuanfudao offers a suite of K-12 education services, including live courses, a database of exam problems, and a popular homework-help app that scans problems and provides instant solutions. The company also operates an AI research institute intended to improve its product intelligence. Yuanfudao says it serves more than 200 million users and derives the majority of its revenues from selling live courses. The startup plans to use proceeds from the latest financing to invest in AI research and to improve its apps' user experience. It competes in China’s large, fast-growing online K-12 tutoring market against players such as Zuoyebang and Yiqizuoye. The company was described in the article as a six-year-old startup focused on the exam-oriented Chinese market. Yuanfudao is a Beijing-based online tutoring company that offers live, app-based tutoring to students. The platform reports more than 160 million students using its mobile apps and about 1 million paying users. Tencent is a previous backer of the company. The article does not disclose revenue or other financial details beyond the fundraising. Yuanfudao has attracted major investors in this round, reflecting continued interest in China’s edtech sector. The company’s recent raise places it among Chinese unicorns valued at more than $1 billion.

Led · Series B · Oct 2013

Amaranth Medical is a privately held medical device company that developed the FORTITUDE bioresorbable scaffold, designed to provide the strength of metal stents without leaving a permanent implant. Its lead product line includes a non‑drug‑eluting FORTITUDE scaffold previously evaluated in a 13‑patient study and a planned drug‑eluting FORTITUDE intended for further clinical evaluation. Results from the initial study, presented at TCT, suggested the scaffold maintained mechanical integrity with late lumen loss comparable to bare metal stents. The company announced an equity investment from Boston Scientific to advance an international clinical study, pursue a CE Mark application, and support development of a next‑generation FORTITUDE scaffold with thinner struts. Amaranth planned to begin enrolling a second cohort in 2014 to evaluate the drug‑eluting scaffold. The company is headquartered in Mountain View, California, with research and manufacturing operations in Singapore and at its Silicon Valley headquarters, and is led by CEO Kamal Ramzipoor. Prior investors named include Charter Life Sciences, Bio*One Capital, Philip Private Equity, DCP Management and Venstar Capital. Amaranth Medical is a Mountain View, California-based medical device company that has created a novel technology platform for the development and manufacturing of fully bioresorbable scaffolds. Led by Kamal Ramzipoor, General Manager and Chief Technical Officer, the company has research and manufacturing operations in Singapore and at its Silicon Valley headquarters. Its lead product is FORTITUDE™, a bioresorbable scaffold intended for treating coronary artery disease. The company intends to use the funds to develop the upcoming CE Mark clinical trial of FORTITUDE. Amaranth closed a $20m Series B financing to advance these clinical and development activities. The financing involved both new and existing investors, reflecting continued support for its platform.